Hemoglobin induces oxidative stress and mitochondrial dysfunction in oligodendrocyte progenitor cells

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Oligodendrocyte progenitor cells (OPCs) are crucial for myelinating axons in the infant brain.
• OPCs are susceptible to oxidative stress, a common factor in brain injuries like neonatal intraventricular hemorrhage (IVH).
• Neonatal IVH releases blood, including the oxidant hemoglobin, into the infant brain, but its direct impact on OPCs is unknown.

Purpose of the Study:

• To investigate the direct effects of hemoglobin on OPCs, specifically focusing on oxidative stress and mitochondrial function.
• To evaluate the protective potential of phenelzine (PLZ), an FDA-approved antioxidant, against hemoglobin-induced damage in OPCs.

Main Methods:

• OPCs were isolated from Sprague Dawley rat pups and cultured.
• Cells were exposed to hemoglobin with and without phenelzine (PLZ).
• Assessed reactive oxygen species (ROS) using DCF-DA, mitochondrial oxygen consumption via Seahorse assay, and cell proliferation with BrdU incorporation.

Main Results:

• Hemoglobin exposure significantly increased intracellular reactive oxygen species (ROS) and impaired mitochondrial function in OPCs.
• Phenelzine (PLZ) treatment effectively reduced hemoglobin-induced oxidative stress and improved OPC mitochondrial bioenergetics.
• While not statistically significant, trends suggested hemoglobin reduced OPC proliferation and PLZ enhanced it (P=0.06).

Conclusions:

• Hemoglobin directly induces mitochondrial dysfunction and oxidative stress in oligodendrocyte progenitor cells (OPCs).
• Antioxidant therapy, exemplified by phenelzine (PLZ), can mitigate these harmful effects.
• Antioxidant interventions may offer a therapeutic strategy for white matter diseases associated with hemoglobin, such as neonatal IVH.